Screener
Tango Therapeutics TNGX Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Tango Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221656
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Operating lease right-of-use assets | 34,652 | 35,624 |
| Restricted cash, net of current portion | 2,139 | 2,139 |
| Other assets | 293 | 303 |
| Total assets | $435,792 | $398,690 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $2,430 | $1,182 |
| Accrued expenses and other current liabilities | 9,068 | 17,759 |
Item 1. Financial Statements.
FAQ
- What is Tango Therapeutics's total assets?
- Tango Therapeutics (TNGX) reported total assets of $435.79M in Q1 2026.
- How has Tango Therapeutics's total assets changed year-over-year?
- Tango Therapeutics's total assets increased by 58.9% year-over-year, from $274.31M to $435.79M.
- What is the long-term trend for Tango Therapeutics's total assets?
- Over 5 years (2020 to 2025), Tango Therapeutics's total assets has grown at a 14.0% compound annual growth rate (CAGR), from $207.25M to $398.69M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Tango Therapeutics's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude